Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102110724 | 10211072 | 4 | F | 201604 | 20160817 | 20140602 | 20160824 | EXP | US-PFIZER INC-2014148266 | PFIZER | 63.00 | YR | M | Y | 120.20000 | KG | 20160824 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102110724 | 10211072 | 1 | PS | REVATIO | SILDENAFIL CITRATE | 1 | UNK | 21845 | FILM-COATED TABLET | ||||||||||
| 102110724 | 10211072 | 2 | SS | REVATIO | SILDENAFIL CITRATE | 1 | Oral | 20 MG, 2X/DAY | A563501 | 21845 | 20 | MG | FILM-COATED TABLET | BID | |||||
| 102110724 | 10211072 | 3 | SS | REVATIO | SILDENAFIL CITRATE | 1 | 20 MG, 3X/DAY | 21845 | 20 | MG | FILM-COATED TABLET | TID | |||||||
| 102110724 | 10211072 | 4 | C | LASIX | FUROSEMIDE | 1 | Oral | 80 MG, 2X/DAY | 0 | 80 | MG | TABLET | BID | ||||||
| 102110724 | 10211072 | 5 | C | XANAX | ALPRAZOLAM | 1 | Oral | 0.5 MG, AS NEEDED | 0 | .5 | MG | TABLET | |||||||
| 102110724 | 10211072 | 6 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 600 MG, 1X/DAY (AT NIGHT) | 0 | 600 | MG | TABLET | QD | ||||||
| 102110724 | 10211072 | 7 | C | OXYCODONE | OXYCODONE | 1 | Oral | 10 MG, 2X/DAY (IN THE MORNING AND AT NIGHT)/(AT 5:00AM AND ONE TABLET AT 5:00PM.) | 0 | 10 | MG | PROLONGED-RELEASE TABLET | BID | ||||||
| 102110724 | 10211072 | 8 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | UNK, AS NEEDED (OXYCODONE HYDROCHLORIDE-10MG, PARACETAMOL-325MG) | 0 | TABLET | |||||||||
| 102110724 | 10211072 | 9 | C | ALBUTEROL. | ALBUTEROL | 1 | Nasal | 2.5 MG, AS NEEDED | 0 | 2.5 | MG | ||||||||
| 102110724 | 10211072 | 10 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG, DAILY | 0 | 81 | MG | ||||||||
| 102110724 | 10211072 | 11 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | Oral | 2 MG, DAILY (EVERY MORNING) | 0 | 2 | MG | TABLET | |||||||
| 102110724 | 10211072 | 12 | C | PEPCID | FAMOTIDINE | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | TABLET | QD | ||||||
| 102110724 | 10211072 | 13 | C | FLUTICASONE | FLUTICASONEFLUTICASONE PROPIONATE | 1 | Nasal | 1 DF, 2X/DAY (ONE PUFF EVERY 12 HOURS)/ (100/50MCG) | 0 | 1 | DF | BID | |||||||
| 102110724 | 10211072 | 14 | C | COZAAR | LOSARTAN POTASSIUM | 1 | Oral | 50 MG, 1X/DAY | 0 | 50 | MG | TABLET | QD | ||||||
| 102110724 | 10211072 | 15 | C | WARFARIN | WARFARIN | 1 | Oral | UNK, DAILY (5MG ONE AND ONE-HALF OR TWO)/(7.5MG DAILY FOR ONE-HALF THE WEEK/10MG DAILY HALF WK | 0 | TABLET | |||||||||
| 102110724 | 10211072 | 16 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 50 MG, 2X/DAY (EACH MORNING AND EACH EVENING) | 0 | 50 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102110724 | 10211072 | 1 | Lung disorder |
| 102110724 | 10211072 | 5 | Anxiety |
| 102110724 | 10211072 | 6 | Neuropathy peripheral |
| 102110724 | 10211072 | 7 | Pain |
| 102110724 | 10211072 | 8 | Breakthrough pain |
| 102110724 | 10211072 | 9 | Dyspnoea |
| 102110724 | 10211072 | 10 | Myocardial infarction |
| 102110724 | 10211072 | 11 | Blood pressure measurement |
| 102110724 | 10211072 | 12 | Dyspepsia |
| 102110724 | 10211072 | 13 | Lung disorder |
| 102110724 | 10211072 | 14 | Blood pressure measurement |
| 102110724 | 10211072 | 15 | Anticoagulant therapy |
| 102110724 | 10211072 | 16 | Blood pressure measurement |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102110724 | 10211072 | OT |
| 102110724 | 10211072 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102110724 | 10211072 | Atrial fibrillation | |
| 102110724 | 10211072 | Dyspnoea | |
| 102110724 | 10211072 | Intentional product use issue | |
| 102110724 | 10211072 | Myocardial infarction | |
| 102110724 | 10211072 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102110724 | 10211072 | 2 | 201209 | 0 | ||
| 102110724 | 10211072 | 4 | 1994 | 0 | ||
| 102110724 | 10211072 | 5 | 1994 | 0 | ||
| 102110724 | 10211072 | 6 | 201506 | 0 | ||
| 102110724 | 10211072 | 7 | 2010 | 0 | ||
| 102110724 | 10211072 | 8 | 2010 | 0 | ||
| 102110724 | 10211072 | 9 | 2012 | 0 | ||
| 102110724 | 10211072 | 10 | 20160413 | 0 | ||
| 102110724 | 10211072 | 11 | 2012 | 0 | ||
| 102110724 | 10211072 | 12 | 1994 | 0 | ||
| 102110724 | 10211072 | 13 | 2012 | 0 | ||
| 102110724 | 10211072 | 14 | 2012 | 0 | ||
| 102110724 | 10211072 | 16 | 2012 | 0 |